On the 22nd, 'Bondam', a meditech company, announced that it had signed an MOU (business agreement) with global real estate company 'Remax Korea' to develop medical data and medical brokerage business.

This agreement ceremony was held with Bondam CEO Lee Dong-kwon and Remax Korea CEO Shin Hee-seong in attendance. In accordance with the detailed business agreement, the two companies plan to build and utilize a real estate network as well as analyze and respond to industry trends.

Shin Hee-seong, CEO of Remax Korea, said, “We plan to provide optimal real estate services based on Remax’s nationwide network, advanced real estate services, and scientific analysis techniques,” and added, “Through a business agreement with Bondam, which has provided services in a scientific manner within the industry, “It will create meaningful synergy,” he said.

Lee Dong-kwon, CEO of Bondam, said, “Based on our ability to analyze hospital treatment rights, we will present optimal strategies for doctors’ operations and openings,” and added, “We plan to cooperate with Remax Korea to strengthen our business competitiveness and create a differentiated brand design unique to Bondam.” .

Original link: https://news.mt.co.kr/mtview.php?no=2022082213205498022&type=1